Force Middle East Bioventures

About The Fund

Force Middle East Bioventures is an investment fund that focuses on early-stage startups in the United States, Europe, and the Middle East, particularly those with technologies and services relevant to Dubai and the Greater Middle East. The fund operates in several sectors, including BioTech, AgroTech, HealthTech, Fitness, Food & Beverage, Material Science, Medical Devices, Hospital Services, Healthcare, Wellness, and it also places an emphasis on being Woman Focused. The fund invests in companies that are at the Early, Pre-Seed, and Seed stages of development. The fund's maximum investment is $500,000, with a minimum investment of $25,000 and a sweet spot of approximately $100,000 for their investments. Their key areas of interest include rapid diagnostics, genomics in population health, digital health, telemedicine, synthetic biology, biomanufacturing, AgTech, 3D printing, and global healthcare supply chain innovations. Force Middle East Bioventures targets companies with vetted commercialization plans, a balanced team of founders with a massive vision, and lean budgets. For these companies, they offer to become a part of their growth story and potentially facilitate their expansion into relevant markets. However, as part of their current focus, the fund is not interested in companies that are developing therapeutics and medical device solutions that require significant regulatory requirements for launch. This stance is reflective of their aim to partner with companies that have the ability to launch products with limited regulatory barriers. The content from their website indicates that they also offer Tech+Bio Consulting Services and have positioned themselves in the market as a global life science consulting entity.